Reuters

NEW DELHI (Reuters) - India's opposition Congress party leader Rahul Gandhi on Thursday demanded a parliamentary probe into stock market moves before and after the exit polls following the country's recently concluded national elections.

(Reporting by Shivam Patel and Sakshi Dayal; Editing by YP Rajesh)

ROME (Reuters) - Corruption in Italy has declined over the last few years but remains a problem, with business owners and the self employed the most affected, a report published on Thursday by the national statistics bureau found.

The reduction, although significant, leaves a large number of Italians, particularly those in business, vulnerable to illicit demands that could impact their livelihoods and the overall economic landscape.

The... (continue reading...)

By Medha Singh

(Reuters) - Trading stocks and bonds on blockchains at scale will remain a dream unless a global standard for cross-border activity is established that allows assets to move seamlessly across blockchains, according to a report published on Thursday.

So-called tokenised assets - which represent the underlying assets - are exchanged on distributed ledger technology (DLT) that are also used for cryptocurrencies. Banks hope... (continue reading...)

NEW YORK (Reuters) - Emerging markets attracted foreign portfolio inflows for a seventh straight month in May thanks to investors pouring money into bonds, but persistently high U.S. interest rates are dimming the outlook, a report from a banking trade group showed.

The Institute of International Finance (IIF) said net non-resident portfolio flows into emerging markets came in at $5.5 billion in May compared to a revised $8.2 billion inflow in April,... (continue reading...)

(Reuters) -Nestle Health Science will buy the rights to Seres Therapeutics' Vowst, the companies said on Thursday, gaining access to the first ever pill alternative to fecal transplants for a deadly infection.

Nestle's unit will pay an undisclosed payment to Massachusetts-based Seres, and the drug maker will also receive capital infusions, the companies said.

Vowst fits within Nestle Health Science's expertise, Moreno Perugini, president... (continue reading...)